Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

You are here: Home » News & Analysis

News & Analysis

Print

China biotech company and industry news and analysis...

Recent Articles

  Sihuan Pharma Announces Second Anti-Virus Partnership with AMMS
  MID Labs of California Raises $51 Million from China Investors
  Hangzhou Joinstar and Response Biomedical in $9 Million Deal
  Yew Bio-Pharm to Distribute Carpal Tunnel Medical Device in China
  Decheng, a China Investor, Participates in Invitae's $120 Million Funding
  Sihuan Pharma: Ebola Drug NDA by Year-End?
  China's BravoVax In-Licenses Rotavirus Vaccine for Infants
  Fosun Pays $607 Million for Portuguese Hospital Chain
  Sihuan Pharma Buys Rights to Ebola Drug from China's AMMS
  ContraFect and China's IVDC Collaborate on Universal Flu Treatment
 
Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
ChinaBio Leadership Retreat 2014
Suzhou, China
October 23-24, 2014
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors